Lyra Therapeutics, Inc. ( LYRA) - Key Metrics
Stock symbol LYRA is outdated, potentially delisted? Maybe it is available on other exchange?
LYRA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q3 | $0.01 | -$3.38 | -$4.16 | -$4.16 |
| 2025Q2 | $0.14 | -$5.51 | -$4.89 | -$4.90 |
| 2025Q1 | $0 | -$0.13 | -$0.13 | -$0.13 |
| 2024Q4 | $0 | -$0.17 | -$0.17 | -$0.17 |
| 2024Q3 | $0 | -$0.18 | -$0.25 | -$0.25 |
LYRA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q3 | ? | -0.48 |
| 2025Q2 | ? | -0.41 |
| 2025Q1 | ? | -12.16 |
| 2024Q4 | ? | -15.30 |
| 2024Q3 | ? | -17.71 |
LYRA
Price: $0.73
52 week price:
Earnings Per Share: -22.90 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 10913
Market Capitalization: 878566